Back to Search
Start Over
Who writes dermatology randomized controlled trials? The need to specify the role of medical writers
- Source :
- Clinical and experimental dermatologyReferences. 46(6)
- Publication Year :
- 2021
-
Abstract
- Medical writers may make major contributions to the preparation of a manuscript, but are not listed as authors. We assessed the prevalence, affiliation and role of medical writers in dermatology randomized controlled trials (RCTs) published in 2019 in the top 7 medical and top 10 dermatology journals. Medical writers were identified in 39/83 trials (47%), all of which were exclusively industry-funded trials (39/47, prevalence 83%). Most studies stated their role as 'medical writing support' and/or 'editorial assistance' (35/39, 90%), but when more information was provided, four studies specified first draft preparation (50% of RCTs in general medical and 1.3% of RCTs in dermatology journals). Medical writers are common in dermatology trials but their role is often vaguely stated. In April 2020 the British Journal or Dermatology and Clinical and Experimental Dermatology adopted CRediT (Contributor Roles Taxonomy), which describes contributions of authors and may help clarify who writes trial manuscripts.
- Subjects :
- medicine.medical_specialty
Dermatology
Journalism, Medical
Medical writing
Medical Writing
Authorship
law.invention
030207 dermatology & venereal diseases
03 medical and health sciences
0302 clinical medicine
Randomized controlled trial
law
030220 oncology & carcinogenesis
Taxonomy (general)
medicine
Humans
Periodicals as Topic
Psychology
Randomized Controlled Trials as Topic
Subjects
Details
- ISSN :
- 13652230
- Volume :
- 46
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Clinical and experimental dermatologyReferences
- Accession number :
- edsair.doi.dedup.....4819eb986b5f4b1c97d8d714d938d7c5